Huntsman Reports Significant Annual Losses, 34% Adjusted EBITDA Decline, and 65% Dividend Cut
summarizeSummary
Huntsman Corporation's 2025 annual report details a sharp decline in financial performance, including a significant operating loss and a 34% drop in Adjusted EBITDA, alongside a substantial 65% dividend cut and major restructuring initiatives.
check_boxKey Events
-
Financial Performance Decline
Reported a 6% decrease in revenues to $5.68 billion and a 13% decrease in gross profit to $751 million for 2025 compared to 2024. Operating loss significantly widened by 424% to $(131) million, and Adjusted EBITDA decreased by 34% to $275 million.
-
Substantial Dividend Cut
The Board of Directors declared a $0.0875 per share cash dividend on November 3, 2025, representing a 65% decrease from the previous dividend.
-
Significant Restructuring Charges
Incurred $148 million in restructuring, impairment, and plant closing costs in 2025, a substantial increase from $39 million in 2024. This includes a $14 million goodwill impairment related to the closure of its Moers, Germany maleic anhydride facility.
-
Legal Settlement Income
Received a final award of approximately $66 million from a long-running litigation against Praxair/Linde in Q1 2025, recognizing $33 million in net income after legal fees.
auto_awesomeAnalysis
Huntsman Corporation's annual 10-K filing confirms a challenging fiscal year 2025, marked by substantial financial deterioration across key metrics. The company reported a significant increase in operating loss and a 34% decline in Adjusted EBITDA. A notable 65% reduction in the quarterly cash dividend signals financial strain and a shift in capital allocation. The company is undergoing significant restructuring, including a facility closure and goodwill impairment, to optimize its cost structure. While a $33 million net income from a legal settlement provides a one-time positive, it does not offset the broader negative financial trends. Investors should monitor the effectiveness of the restructuring efforts and the company's ability to improve profitability in the face of ongoing market challenges.
At the time of this filing, HUN was trading at $13.46 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $7.30 to $18.53. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.